Likes
Followers
Subscribers
Followers

Thursday, November 30, 2023
About Us
Website Terms of Use
Privacy Policy
Contact

The Dales Report - We Set The Narrative - We Set The Narrative

Cannabis
Psychedelics
Crypto/NFTs
Podcasts
Trends
Facebook
Twitter
YouTube
Instagram

Home
Numinus Wellness
Page 3

Browsing Tag

Numinus Wellness

Numinus Expands Natural Psychedelic Research with New Biosecurity License

Mar 14, 2022

Numinus Wellness CEO Discusses MDMA And Psilocybin Trials

Mar 7, 2022

TDR’s Top 5 Psychedelic Developments For The Week Of January 24

Jan 29, 2022

Numinus Identified As A Licensed Psilocybin Supplier By Health Canada

Jan 27, 2022

TDR’s Top 5 Psychedelic Developments For The Week Of January 17

Jan 22, 2022

Breaking Down Numinus Wellness Quarterly Results

Jan 21, 2022

Numinus Wellness Prepares For An MDMA Clinical Trial

Jan 19, 2022

Numinus Announces Key Milestones in MAPS-Sponsored MDMA-Assisted Therapy for PTSD Clinical Trial

Jan 19, 2022

Numinus Submits Its Phase 1 Psilocybin Trial Application

Jan 14, 2022

Numinus Submits Clinical Trial Application for Phase 1 Trial on Proprietary Psilocybin Product

Jan 14, 2022

Previous 1 2 3 4 5 … 9 Next

Latest Articles

Numinus Reports Q4 & Full Year Fiscal 2023 Results, Including Greatly Reduced Cash Burn Rate

Nov 29, 2023

Cansortium Reports Record Revenue In Its Fiscal Third Quarter 2023 Financial Results

Nov 29, 2023

Warren Buffett Praises Charlie Munger Following The Legendary Investor’s Death

Nov 29, 2023

Arkansas Cannabis Sales On Pace For Annual Record, October Trends Show

Nov 29, 2023

Popular Interviews

Doug Drysdale On Cybin, Mental Health, And CYB003 Results

Nov 3, 2023

Trade To Black On Michigan, Ohio, And Psilocybin’s Appeal

Oct 31, 2023

The Cannabist’s Jesse Channon On Cannabis Marketing

Nov 1, 2023

Financial Giants And The NRA Are Lobbying For Banking Reform

Oct 30, 2023

TDR

CRYPTO/NFTs
PSYCHEDELICS
CANNABIS
TRADE TO BLACK
YOUTUBE
TRENDS

© 2023 - The Dales Report. All Rights Reserved.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More